Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia

Malignant hyperthermia (MH) is a metabolic myopathy with an abnormal release of calcium by the sarcoplasmic reticulum (SR), triggered by volatile anesthetics and succinylcholine. Similarly, caffeine enhances Ca2+release by the SR in vitro. In a prospective, randomized study, high‐energy phosphates were studied by intramuscular 31‐phosphorus magnetic resonance spectroscopy (31P‐MRS) in 10 MH‐susceptible (MHS) and 7 MH‐nonsusceptible (MHN) subjects before and after injection of 0.5 ml caffeine (20 mM). Intramuscular energy balance, measured by the ratios of Pi/PCr and Pi/γ‐ATP, did not differ between MHS and MHN patients before and after intramuscular caffeine injection. However, within each group, Pi/PCr and Pi/γ‐ATP increased significantly only in the MHS group. Intramuscular caffeine injection seemed to impair the metabolic balance in MHS individuals. This may reflect a local calcium overload leading to consumption of high‐energy phosphates and increase of inorganic phosphate. Intramuscular stimulation by caffeine and 31P‐MRS may provide a valuable tool to investigate MH‐related metabolic disturbances. Muscle Nerve 28: 353–358, 2003

[1]  A. Herrmann-Frank,et al.  Caffeine and excitation–contraction coupling in skeletal muscle: a stimulating story , 1999, Journal of Muscle Research & Cell Motility.

[2]  N. Roewer,et al.  Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test , 2002, The Lancet.

[3]  M. Tarnopolsky,et al.  Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers. , 2000, Journal of applied physiology.

[4]  D. Hahn,et al.  Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans , 2000, European Radiology.

[5]  B. Tavernier,et al.  Effects of halothane on mechanical response of skeletal muscle from malignant hyperthermia susceptible patients. , 1998, Archives of Physiology and Biochemistry.

[6]  S. Confort-Gouny,et al.  31Phosphorus Magnetic Resonance Spectroscopy Characterization of Muscular Metabolic Anomalies in Patients with Malignant Hyperthermia: Application to Diagnosis , 1998, Anesthesiology.

[7]  L. Bossaert,et al.  Slower recovery of muscle phosphocreatine in malignant hyperthermia-susceptible individuals assessed by 31P-MR spectroscopy , 1997, Journal of Neurology.

[8]  T R Brown,et al.  NOE Enhancements and T1 Relaxation Times of Phosphorylated Metabolites in Human Calf Muscle at 1.5 Tesla , 1995, Magnetic resonance in medicine.

[9]  L. Spriet,et al.  Metabolic, catecholamine, and exercise performance responses to various doses of caffeine. , 1995, Journal of applied physiology.

[10]  R. Coronado,et al.  Structure and function of ryanodine receptors. , 1994, The American journal of physiology.

[11]  A. Benabid,et al.  Improved Noninvasive Diagnostic Testing for Malignant Hyperthermia Susceptibility from a Combination of Metabolites Determined In Vivo with 31P-Magnetic Resonance Spectroscopy , 1993, Anesthesiology.

[12]  E. Neher,et al.  Functional expression of the calcium release channel from skeletal muscle ryanodine receptor cDNA , 1989, FEBS letters.

[13]  B. Chance,et al.  Non‐invasive Evaluation of Maliganant Hyperthermia Susceptibility with Phosphorus Nuclear Magnetic Resonance Spectroscopy , 1988 .

[14]  A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. , 1984, British journal of anaesthesia.

[15]  J. Mccomb,et al.  Serum myoglobin after cardiac catheterisation. , 1982, British heart journal.